We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$3.22B
AUM Growth
+$177M
Cap. Flow
-$69.6M
Cap. Flow %
-2.16%
Top 10 Hldgs %
16.16%
Holding
348
New
47
Increased
93
Reduced
73
Closed
32

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$31M
2
LKQ icon
LKQ Corp
LKQ
+$24.8M
3
AME icon
Ametek
AME
+$22.1M
4
SBAC icon
SBA Communications
SBAC
+$20.3M
5
WSO icon
Watsco Inc
WSO
+$17.8M

Sector Composition

Rank Sector Weight
1 Industrials 20.87%
2 Technology 17.15%
3 Consumer Discretionary 16.4%
4 Healthcare 10.9%
5 Financials 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPM icon
301
Evolution Petroleum
EPM
$131M
$151K ﹤0.01%
+12,201
New +$147K
NPKI
302
NPK International
NPKI
$1.14B
$149K ﹤0.01%
+12,118
New +$151K
LFCR icon
303
Lifecore Biomedical
LFCR
$190M
$147K ﹤0.01%
+12,109
New +$145K
ITMN
304
CALL
DELISTED
INTERMUNE INC
ITMN
$147K ﹤0.01%
10,000
-10,500
-51% -$145K
PNNT
305
Pennant Park Investment Corp
PNNT
$241M
$143K ﹤0.01%
+12,358
New +$142K
IDXX icon
306
CALL
Idexx Laboratories
IDXX
$46.2B
$128K ﹤0.01%
2,400
+200
+9% +$10.5K
GMAN
307
DELISTED
Gordmans Stores, Inc.
GMAN
$102K ﹤0.01%
+13,363
New +$126K
RLD
308
DELISTED
REALD INC COM STK
RLD
$100K ﹤0.01%
+11,669
New +$91.4K
ACCL
309
DELISTED
Accelrys Inc
ACCL
$100K ﹤0.01%
+10,529
New +$98.9K
MASI
310
CALL
DELISTED
Masimo
MASI
$47K ﹤0.01%
+1,600
New +$44.8K
RGLD icon
311
CALL
Royal Gold
RGLD
$19.5B
$46K ﹤0.01%
1,000
-106,800
-99% -$5.04M
VRTX icon
312
CALL
Vertex Pharmaceuticals
VRTX
$126B
$15K ﹤0.01%
200
AMGN icon
313
Amgen
AMGN
$222B
$13K ﹤0.01%
+113
New +$12.9K
DXCM icon
314
CALL
DexCom
DXCM
$32B
$11K ﹤0.01%
1,200
PFE icon
315
Pfizer
PFE
$153B
$11K ﹤0.01%
+369
New +$10.7K
BAC.WS.A
316
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$1K ﹤0.01%
+90
New +$564
ALNY icon
317
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
-25,000
Closed -$1.6M
AME icon
318
Ametek
AME
$58.2B
-479,641
Closed -$22.1M
ASB icon
319
Associated Banc-Corp
ASB
$5.91B
-484,600
Closed -$7.51M
CLDX icon
320
CALL
Celldex Therapeutics
CLDX
$3.28B
-333
Closed -$177K
CLDX icon
321
Celldex Therapeutics
CLDX
$3.28B
-3,635
Closed -$1.93M
DGX icon
322
CALL
Quest Diagnostics
DGX
$26.3B
-3,300
Closed -$204K
DOC icon
323
Healthpeak Properties
DOC
$14.8B
-109,800
Closed -$4.09M
FITB
324
Fifth Third Bancorp
FITB
$51.8B
-42,200
Closed -$762K
HCA icon
325
HCA Healthcare
HCA
$89.5B
-15,000
Closed -$641K

Similar funds

ArrowMark Colorado Holdings's Q4 2013 Portfolio in Review

As of Q4 2013, ArrowMark Colorado Holdings held 348 positions worth $3.22B, up 5.8% from $3.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ArrowMark Colorado Holdings's Q4 2013 filing shows 47 new, 93 increased, 73 reduced and 32 closed positions. Its largest new stake was Lazard: 264,400 shares worth $12M. The largest sale was Polaris, an estimated $31M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • ArrowMark Colorado Holdings's largest Q4 2013 buy was Lazard: 264,400 shares worth $12M.
  • ArrowMark Colorado Holdings added most to Carter's in Q4 2013, an estimated $26.8M increase.
  • ArrowMark Colorado Holdings's biggest Q4 2013 reduction was Polaris, cutting an estimated $31M.
  • ArrowMark Colorado Holdings fully exited Ametek in Q4 2013, selling an estimated $22.1M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 16% of its $3.22B portfolio in Q4 2013.
  • ArrowMark Colorado Holdings opened 47 new positions and closed 32 in Q4 2013.
  • ArrowMark Colorado Holdings's portfolio value rose 5.8% quarter-over-quarter to $3.22B.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.